Investor Type

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top right of this site.
Institutional Investor Advisor Individual Investor


Health Care Sector Update

March 27, 2020

Senior Health Care Analysts Marshall Gordon and Nicholas Wu join Vinay Nadkarni to discuss the likely trajectory of the COVID-19 outbreak in the U.S., assess the impact on biopharmaceuticals, managed care, medical devices and other subsectors and analyze potential treatments for the virus. 

Marshall Gordon

Senior Analyst - Health Care
21 Years experience
13 Years at ClearBridge

Nicholas Wu, PhD

Senior Analyst - Health Care
19 Years experience
14 Years at ClearBridge

Vinay Nadkarni

Head of Global Business Development
28 Years experience
25 Years at ClearBridge

Related Perspectives

  • All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information. 

  • Past performance is no guarantee of future results.